Fumitaka Muramatsu
- Molecular Biology
- Cancer Research top 10%
- Oncology
- Surgery
- Pharmacology top 10%
- Co-authors
- Nobuyuki TakakuraHiroyasu KidoyaHisamichi NaitoTomohiro IbaTaku WakabayashiKentaro KajiyaSusumu SakimotoKazuhiro Takara
- Topics
- Angiogenesis and VEGF in Cancer (7 papers)Apelin-related biomedical research (6 papers)MicroRNA in disease regulation (4 papers)
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Fumitaka Muramatsu
22 papers receiving 806 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 458
- Cancer Research 185
- Oncology 151
- Surgery 150
- Pharmacology 141
Countries citing papers authored by Fumitaka Muramatsu
This map shows the geographic impact of Fumitaka Muramatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumitaka Muramatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumitaka Muramatsu more than expected).
Fields of papers citing papers by Fumitaka Muramatsu
This network shows the impact of papers produced by Fumitaka Muramatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumitaka Muramatsu. The network helps show where Fumitaka Muramatsu may publish in the future.
Co-authorship network of co-authors of Fumitaka Muramatsu
This figure shows the co-authorship network connecting the top 25 collaborators of Fumitaka Muramatsu. A scholar is included among the top collaborators of Fumitaka Muramatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumitaka Muramatsu. Fumitaka Muramatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 3 | |
| 4 | 9 | |
| 5 | 11 | |
| 6 | 18 | |
| 7 | 23 | |
| 8 | 28 | |
| 9 | 26 | |
| 10 | 33 | |
| 11 | 141 | |
| 12 | 40 | |
| 13 | 17 | |
| 14 | 67 | |
| 15 | 30 | |
| 16 | 57 | |
| 17 | 107 | |
| 18 | 90 | |
| 19 | 55 | |
| 20 | 36 |
About Fumitaka Muramatsu
Fumitaka Muramatsu is a scholar working on Cancer Research, Cell Biology and Pharmacology, having authored 23 papers that have together received 809 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Apelin-related biomedical research (6 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (185 citations), Pharmacology (141 citations) and Molecular Biology (458 citations). Fumitaka Muramatsu has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Nobuyuki Takakura, Hiroyasu Kidoya, Hisamichi Naito, Tomohiro Iba, Taku Wakabayashi, Kentaro Kajiya, Susumu Sakimoto, Kazuhiro Takara, Yumiko Hayashi and Keitaro Yamane. Their work appears in journals such as Nature Communications, Molecular and Cellular Biology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.